Novartis AG Common Stock · Total Non-Current Liabilities

Latest reported$41.74Bperiod endingDec 31, 2025

NVS FY Total Non-Current Liabilities ($7.01B → $41.74B)

Annual total non-current liabilities

High-resolution chart · PNG

NVS total non-current liabilities history

Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Novartis AG Common Stock Total Non-Current Liabilities — Annual fiscal periods (USD)
Period ending	Total Non-Current Liabilities (USD)
Dec 31, 2025	41,742,072,000
Dec 31, 2024	29,428,000,000
Dec 31, 2023	26,805,000,000
Dec 31, 2022	29,374,000,000
Dec 31, 2021	33,765,000,000
Dec 31, 2020	42,464,000,000
Dec 31, 2019	34,597,850,467
Dec 31, 2018	37,264,000,000
Dec 31, 2017	35,449,000,000
Dec 31, 2016	33,024,000,000
Dec 31, 2015	30,726,000,000
Dec 31, 2014	27,570,000,000
Dec 31, 2013	25,414,000,000
Dec 31, 2012	30,946,000,000
Dec 31, 2011	28,408,000,000
Dec 31, 2010	28,891,000,000
Dec 31, 2009	18,573,000,000
Dec 31, 2008	11,358,000,000
Dec 31, 2007	9,415,000,000
Dec 31, 2006	10,480,000,000
Dec 31, 2005	9,240,000,000
Dec 31, 2004	9,470,000,000
Dec 31, 2003	9,478,000,000
Dec 31, 2002	8,440,000,000
Dec 31, 2001	6,160,000,000
Dec 31, 2000	5,863,000,000
Dec 31, 1999	6,715,000,000
Dec 31, 1998	7,009,447,674